LIC MF Healthcare Fund

The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.

Growthvine rating: 3/5 — ranked #28 of 87 in category.

Fund basics

CategoryEquity: Sectoral
NAV₹34.73 (as of 2026-11-13)
AUM₹99 Cr
Expense ratio2.10%
RiskometerVery High
Fund managerDhaval Sangoi
Exit loadFor units in excess of 12% of the investment, 1% will be charged for redemption within 90 days

Performance & risk

Sharpe ratio0.92
Standard deviation16.11%
Max drawdown−15.35%
Alpha-1.21
Beta0.95

Over 5 years, captured 87.2% of NIFTY Pharma's upside and 84.1% of its downside.

Market cap allocation

Large cap28.9%
Mid cap32.5%
Small cap38.5%

Concentration

Top 5 holdings33.7%
Top 10 holdings55.5%
Total holdings27

Top holdings

Top sectors

Calendar-year track record

YearReturnQuartileCategory rank
2026 (partial)19.3%Q1 (Top)#12 of 76
2025−4.4%Q4 (Bottom)#54 of 69
202442.1%Q1 (Top)#6 of 58